Treatment of pediculosis capitis with thiabendazole: A pilot study

International Journal of Dermatology

Volumn 42, Issue 12, 2003, Pages 973-976

  Namazi, Mohammad Reza ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARASITIC AGENT; BETA TUBULIN; TIABENDAZOLE;

CHOLINERGIC ACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; COMMUNICABLE DISEASE; CONFERENCE PAPER; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG EFFICACY; EPIDEMIOLOGICAL DATA; HUMAN; INFESTATION; LOW DRUG DOSE; MICROTUBULE ASSEMBLY; MONOTHERAPY; NAUSEA; PEDICULOSIS; PEDICULOSIS CAPITIS; PEDICULUS; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SYNAPTIC TRANSMISSION; VERTIGO;

ADMINISTRATION, ORAL; ANTINEMATODAL AGENTS; CHILD; FEMALE; HUMANS; LICE INFESTATIONS; PILOT PROJECTS; SCALP DERMATOSES; THIABENDAZOLE; TREATMENT OUTCOME;

EID: 0346903106     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2003.01996.x     Document Type: Conference Paper

References (22)

1. Chosidow O. Scabies and pediculosis. Lancet 2000; 355: 819-826.
2. Eichenfield LF, Colon-Fontanez F. Treatment of head lice. Pediatr Infect Dis J 1998; 17: 419-420.
3. Downs AMR, Stafford KA, Coles GC. Head lice prevalence in school children and insecticide resistance. Parasitol Today 1999; 15: 1-3.
4. Price JH, Burkhart CN, Burkhart CG, Islam R. School nurses' perception of and experience with head lice. J Sch Health 1999; 69; 153-158.
5. Namazi MR. Levamisole: A safe and economical weapon against pediculosis. Int J Dermatol 2001; 40: 292-294.
6. Burkhart CG, Burkhart CN, Burkhart KM. An assessment of topical and oral prescription and over-the-counter treatments for head lice. J Am Acad Dermatol 1998; 38: 979-982.
7. Mumcuoglu KY. Prevention and treatment of head lice in childhood. Paediatr Drugs 1999; 1: 211-218.
8. Mumcuoglu KY, Hemingway J, Miller J, et al. Permethrin resistance in the head louse Pediculus capitis from Israel. Med Vet Entomol 1995; 9: 427-432.
9. Schachner LA. Treatment resistant head lice: Alternative therapeutic approaches. Pediatr Dermatol 1997; 14: 409-410.
10. Barkwel R, Shieldes S. Death associated with ivermectin treatment of scabies. Lancet 1997; 349: 1144-1145.
11. Reintjes R, Hoek C. Death associated with ivermectin treatment of scabies. Lancet 1997; 350: 215.
12. Coyne PE, Addiss DG. Death associated with ivermectin treatment of scabies. Lancet 1997; 350: 215-216.
13. Hipolito RB, Mallorca FG, Zunigo-Macraig ZO, et al. Head lice infestation: Single drug versus combination therapy with one percent permethrin and trimethoprim/sulfamethoxazole. Pediatrics Available at: http://www.pediatrics.org/ceji/content/full/107/3/e30.
14. Pollack RJ. Head lice infestation: Single drug versus combination therapy (Letter). Pediatrics 2001; 108: 1393.
15. Beck MH, Portnoy B. Severe erythema multiforme complicated by fatal gastro-intestinal involvement following co-trimoxazole therapy. Clin Exp Dermatol 1979; 4: 201-204.
16. Goldsmith RS. Clinical pharmacology of the anthelmintic drugs. In: Katzung BG, ed. Basic and Clinical Pharmacology. New York: Appleton & Lange, 2001: 918-919.
17. Hernandez-Perez E. Topically applied thiabendazole in the treatment of scabies. Arch Dermatol 1976; 112: 1400-1401.
18. Hernandez-Perez E, Santos LR, Bechelli CA. Tiabendazole en escabiosis. Med Cutan 1969; 3: 509-511.
19. Tavares De Mellos E, Uthida Tanaka A. Escabiosis etiabendazole. Rev Paulista Med 1970; 77: 77-80.
20. Tracy JW, Webster LT. Drugs used in the chemotherapy of helminthiasis. In: Hardman JE, Limbird LE, eds. Goodman and Gilman's the Pharmacologic Basis of Therapeutics. New York: McGraw-Hill, 2001: 1126.
21. Lundy J, Lovet HJ, Conran P, Goldblatt PJ. Thiabendazole: A potential adjuvant in cancer therapy. Surgery 1976; 80: 363-340.
22. Renoux G. The general immunopharmacology of levamisole. Drugs 1980; 20: 89-99.